tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

SNY Stock Latest News

Amgen (NASDAQ:AMGN) Loses Patent Battle to Sanofi, Regeneron
Market NewsAmgen (NASDAQ:AMGN) Loses Patent Battle to Sanofi, Regeneron
18d ago
SNY
AMGN
Maze Therapeutics announces license agreement with Sanofi for MZE001
The FlyMaze Therapeutics announces license agreement with Sanofi for MZE001
1M ago
SNY
Sanofi downgraded to Sell from Hold at Deutsche Bank
The FlySanofi downgraded to Sell from Hold at Deutsche Bank
1M ago
SNY
Sanofi downgraded to Sell from Hold at Deutsche Bank
The FlySanofi downgraded to Sell from Hold at Deutsche Bank
1M ago
SNY
Sanofi completes acquisition of Provention Bio
The FlySanofi completes acquisition of Provention Bio
1M ago
SNY
PRVB
Sanofi confirms FY23 business EPS view of up low single digits at CER
The FlySanofi confirms FY23 business EPS view of up low single digits at CER
1M ago
SNY
Sanofi reports Q1 business EPS EUR 2.16, up 11.9% at CER
The FlySanofi reports Q1 business EPS EUR 2.16, up 11.9% at CER
1M ago
SNY
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention
The FlyHart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention
1M ago
SNY
PRVB
ALX Oncology enters clinical trial collaboration with Sanofi
The FlyALX Oncology enters clinical trial collaboration with Sanofi
1M ago
SNY
ALXO
SNY Upcoming Earnings Report: What to Expect?
Pre-EarningsSNY Upcoming Earnings Report: What to Expect?
1M ago
SNY
Sanofi announces launch of AVAXIM Junior in U.K.
The FlySanofi announces launch of AVAXIM Junior in U.K.
1M ago
SNY
Sanofi price target raised to EUR 90 from EUR 85 at Deutsche Bank
The FlySanofi price target raised to EUR 90 from EUR 85 at Deutsche Bank
2M ago
SNY
Sanofi price target raised to EUR 108 from EUR 102 at Guggenheim
The FlySanofi price target raised to EUR 108 from EUR 102 at Guggenheim
2M ago
SNY
Sanofi announces withdrawal, refiling of premerger notice on Provention Bio deal
The FlySanofi announces withdrawal, refiling of premerger notice on Provention Bio deal
2M ago
SNY
PRVB
Sanofi to Spin Off India Consumer Unit
Market NewsSanofi to Spin Off India Consumer Unit
2M ago
SNY
IGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M
The FlyIGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M
2M ago
SNY
IGMS
Regeneron price target raised to $650 from $605 at BofA
The FlyRegeneron price target raised to $650 from $605 at BofA
2M ago
SNY
REGN
Sanofi price target raised to EUR 105 from EUR 100 at Berenberg
The FlySanofi price target raised to EUR 105 from EUR 100 at Berenberg
2M ago
SNY
Sanofi price target raised to $60 from $55 at Argus
The FlySanofi price target raised to $60 from $55 at Argus
2M ago
SNY
Sanofi upgraded to Overweight from Equal Weight at Barclays
The FlySanofi upgraded to Overweight from Equal Weight at Barclays
2M ago
SNY
Sanofi Gains after Dupxient Shows Promise in COPD
Market NewsSanofi Gains after Dupxient Shows Promise in COPD
2M ago
SNY
Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
The FlyRegeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
2M ago
SNY
REGN